Sign in Create account

Max Healthcare Institute Limited

Healthcare · Healthcare Services

NSE: MAXHEALTH BSE: 543220
₹929.80
▼ -52.30 (-5.33%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
77/100
Strong
Valuation
—/100
Expensive
Momentum
26/100
Bearish

QVM read Quality, pricey and fading Quality Strong, Valuation Expensive, Momentum Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

About

Max Healthcare Institute Limited is an Indian for-profit private hospital chain headquartered in Delhi. As of June 2025, Max Healthcare operates 22 hospitals, with a total of over 5,000 beds, primarily in North India.

Source: Wikipedia

Key Metrics

Market Capitalization
₹90,492 Cr
PE (TTM)
126.0
Industry median 50.2 (44 companies)
Price to Book
8.4
PEG (TTM)
184.7
Institutions holding %
71.74%
FII + DII, latest filed period
Piotroski Score
3
Relative return vs Nifty50, qtr %
-13.2
Relative return vs Sector, qtr %
-15.7
Free Cash Flow
₹149 Cr
as of March 31, 2026
Industry median ₹1 Cr (75 companies)
EPS Growth (YoY)
0.58%
as of June 30, 2026
Industry median 13.27% (57 companies)
Net Profit Growth (TTM)
0.73%
as of June 30, 2026
Industry median 7.21% (57 companies)
Operating Revenue Growth (TTM)
8.30%
as of June 30, 2026
Industry median 12.82% (57 companies)
Profit Growth (YoY)
0.95%
as of June 30, 2026
Industry median 8.53% (57 companies)
Revenue Growth (YoY)
12.81%
as of June 30, 2026
Industry median 18.84% (52 companies)
Current Ratio
0.89
as of March 31, 2026
Industry median 2.06 (74 companies)
Debt to Equity
0.32
as of March 31, 2026
Industry median 0.11 (62 companies)
Interest Coverage
22.72
as of June 30, 2026
Industry median 7.94 (57 companies)
Net Margin
21.41%
as of June 30, 2026
Industry median 9.88% (61 companies)
Operating Margin (EBIT)
30.40%
as of June 30, 2026
Industry median 17.21% (61 companies)
Operating Margin (TTM)
32.73%
as of June 30, 2026
Industry median 16.20% (59 companies)
Return on Assets
8.37%
as of March 31, 2026
Industry median 5.40% (58 companies)
Return on Capital Employed
12.70%
as of March 31, 2026
Industry median 10.44% (56 companies)
Return on Equity
13.42%
as of March 31, 2026
Industry median 10.16% (58 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

4 of 8 met
  • No Net profit is higher than a year earlier in each of the last 4 quarters
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • Yes Quality score is Strong (70 or more)
  • No Piotroski F-score is 7 or more (score 3)
  • Yes Debt to equity is below 0.5 (0.32)
  • No Return on equity is 15% or more (13.4%)
  • Yes Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

3 of 3 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

0 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

1 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Buy Zone)
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-5.3%
Low 907.7000 · High 976.3000
1W return
-12.3%
Low 907.7000 · High 1055.8000
1M return
-10.8%
Low 907.7000 · High 1072.6000
52W return
-16.5%
Low 903.0000 · High 1221.9000
Lifetime High ₹1301.4000 (July 3, 2025)
Lifetime Low ₹103.6500 (Oct. 29, 2020)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish0
Bearish6
5D
984.0
10D
1005.4
20D
1016.4
50D
1030.3
100D
1037.3
200D
1033.9

Delivery and volume

Day avg. delivery
53.2%
Week avg. delivery
57.1%
Month avg. delivery
57.2%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

937.93
Pivot
First resistance968.17
Second resistance1006.53
Third resistance1036.77
First support899.57
Second support869.33
Third support830.97
Day RSI28.1
Day MFI28.4
Day MACD-10.87
Day MACD signal-2.40

Beta

1M0.21
3M0.71
1Y0.66
3Y0.71

Price change analysis

↓ -10.8%
Over 1 Month
LowHigh
907.701072.60
↓ -18.4%
Over 3 Months
LowHigh
907.701167.90
↓ -3.0%
Over 6 Months
LowHigh
903.001167.90
↓ -16.5%
Over 1 Year
LowHigh
903.001221.90
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 126.0 (own history: 115.8–174.1)
Buy Zone

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹783 Cr
Net profit (June 30, 2026)
₹168 Cr
Basic EPS (June 30, 2026)
₹1.7200

Ranks #2 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter23.71%
  • Mutual funds18.68%
  • FII/FPI41.78%
  • Other DII11.28%
  • Public4.55%

Largest holders

NameCategoryShares %Shares
Abhay SoiPromoter23.7100%230717699
Nps Trust A/C through various schemesPublic3.4500%33592400
New World Fund IncPublic3.2900%32036039
Government Of SingaporePublic3.2800%31951261
Hdfc Mutual Fund through various schemesPublic3.0400%29631898

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 23.71% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings decreased from 45.39% to 41.78% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings increased from 16.30% to 18.68% in Jun 2026 qtr

83 mutual fund schemes also hold this stock.

All shareholding details →

Insider trading, SAST & pledges

All 169 insider trades, 26 SAST, 25 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
26 Aug 2022 Kayak Investments Holding Pte. Ltd. Promoter Sell 0 ₹0
26 Aug 2022 Abhay Soi Promoter Buy 0 ₹0
17 Aug 2022 Kayak Investments Holding Pte. Ltd. Promoter Sell 0 ₹0
6 Apr 2022 Kayak Investments Holding Pte. Ltd. Promoter Sell 0 ₹0
17 Dec 2021 Ruchi Mahajan Other Sell 0 ₹0
17 Dec 2021 BalKishan Sharma Other Sell 0 ₹0
15 Dec 2021 BalKishan Sharma Other Sell 0 ₹0
15 Dec 2021 Sandeep Tanwar Other Sell 0 ₹0
15 Dec 2021 Manish Luthra Other Sell 0 ₹0
15 Dec 2021 Poonam Das Other Pledge 0 ₹3.38 Cr

All insider and SAST disclosures →

Deals (Bulk & Block)

All 80 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
30 Mar 2026 CITIGROUP GLOBAL MARKETS SINGAPORE PTE LIMITED Block Sell 588,678 969.0000 BSE
30 Mar 2026 BNP PARIBAS FINANCIAL MARKETS Block Buy 588,678 969.0000 BSE
18 Mar 2026 CITIGROUP GLOBAL MARKETS SINGAPORE PTE LIMITED Block Buy 794,904 976.0000 NSE
18 Mar 2026 CITIGROUP GLOBAL MARKETS MAURITIUS PVT LTD Block Sell 794,904 976.0000 NSE
18 Mar 2026 CITIGROUP GLOBAL MARKETS SINGAPORE PTE LIMITED Block Buy 794,904 976.0000 NSE
18 Mar 2026 CITIGROUP GLOBAL MARKETS MAURITIUS PVT LTD Block Sell 794,904 976.0000 NSE
12 Nov 2025 BNP PARIBAS FINANCIAL MARKETS Block Sell 92,289 1095.4000 BSE
12 Nov 2025 SOCIETE GENERALE Block Buy 92,289 1095.4000 BSE
29 Sep 2025 BNP PARIBAS FINANCIAL MARKETS Bulk Sell 8,290,713 1111.6600 NSE
29 Sep 2025 BNP PARIBAS FINANCIAL MARKETS Bulk Buy 353,042 1125.0200 NSE

All bulk and block deals →

Dividends

Full dividend history →
Last 12 months ₹2.00 per share
Dividend yield 0.22%
Ex-dateSubjectPer share (₹)Record date
3 Jul 2026 Dividend - Rs 2 Per Share 2.0000 3 Jul 2026
4 Jul 2025 Dividend - Rs 1.50 Per Share 1.5000 4 Jul 2025
23 Aug 2024 Dividend - Rs 1.5 Per Share 1.5000 23 Aug 2024
8 Sep 2023 Dividend - Re 1 Per Share 1.0000 8 Sep 2023

Board Meetings

View board meeting history →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
13 Aug 2026 Financial Results Yes
21 May 2026 Financial Results/Dividend Yes
5 Feb 2026 Financial Results Yes
14 Nov 2025 Financial Results Yes
13 Aug 2025 Financial Results Yes

Corporate Announcements

All 758 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
29 Sep 2026 Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company Max Healthcare Institute Limited has informed the Exchange about disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
29 Sep 2026 Company Update Max Healthcare Institute Ltd - 543220 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
25 Sep 2026 Trading Window Max Healthcare Institute Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
25 Sep 2026 Insider Trading / SAST Max Healthcare Institute Ltd - 543220 - Closure of Trading Window
20 Sep 2026 Copy of Newspaper Publication Max Healthcare Institute Limited has informed the Exchange about Copy of Newspaper Publication for Postal Ballot Notice
20 Sep 2026 Company Update Max Healthcare Institute Ltd - 543220 - Announcement under Regulation 30 (LODR)-Newspaper Publication
19 Sep 2026 AGM/EGM Max Healthcare Institute Ltd - 543220 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
19 Sep 2026 Shareholders meeting Max Healthcare Institute Limited has informed the Exchange regarding Postal Ballot Notice.
18 Sep 2026 Company Update Max Healthcare Institute Ltd - 543220 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
18 Sep 2026 General Updates Max Healthcare Institute Limited has informed the Exchange about disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Strong net profit margin (21.4%)
  • Comfortable interest coverage (22.7x)

Weaknesses

  • Tight liquidity (Current Ratio 0.89)

Opportunities

  • RSI in oversold territory (28.1) -- a technical rebound zone

Threats

  • PE above 35 (126.0) -- priced for continued strong execution

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Single-stock futures and a real listed options chain available for this stock -- OI buildup, PCR, Max Pain and Greeks are all on the full F&O page.

Part of: NIFTY 100, NIFTY 100, NIFTY 200, NIFTY 200, NIFTY 50, NIFTY 50, NIFTY 500, NIFTY 500

Frequently asked questions about Max Healthcare Institute Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.